CA3025988A1 - Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein - Google Patents
Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein Download PDFInfo
- Publication number
- CA3025988A1 CA3025988A1 CA3025988A CA3025988A CA3025988A1 CA 3025988 A1 CA3025988 A1 CA 3025988A1 CA 3025988 A CA3025988 A CA 3025988A CA 3025988 A CA3025988 A CA 3025988A CA 3025988 A1 CA3025988 A1 CA 3025988A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- conjugate
- pmol
- ring
- moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/10—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16305640.1 | 2016-06-02 | ||
| EP16305640 | 2016-06-02 | ||
| PCT/EP2017/063447 WO2017207754A1 (en) | 2016-06-02 | 2017-06-02 | Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3025988A1 true CA3025988A1 (en) | 2017-12-07 |
Family
ID=56121007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3025988A Abandoned CA3025988A1 (en) | 2016-06-02 | 2017-06-02 | Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein |
Country Status (13)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2018014929A (es) * | 2016-06-02 | 2019-08-26 | Sanofi Sa | Conjugados de un agente farmaceutico y una porcion capaz de unirse a una proteina sensora de glucosa. |
| CN111433193A (zh) | 2017-12-01 | 2020-07-17 | 赛诺菲 | 药剂和能够结合至葡萄糖传感蛋白的部分的新型缀合物 |
| KR20230153387A (ko) | 2021-02-02 | 2023-11-06 | 리미널 바이오사이언시스 리미티드 | Gpr84 길항제 및 이의 용도 |
| JP2024506858A (ja) | 2021-02-02 | 2024-02-15 | リミナル・バイオサイエンシーズ・リミテッド | Gpr84アンタゴニストおよびその使用 |
| CN115920081B (zh) * | 2022-11-02 | 2024-07-19 | 重庆大学 | 红细胞膜自发定向包被ros响应的纳米前药及其应用 |
| WO2025199666A1 (en) * | 2024-03-25 | 2025-10-02 | Canwell Biotech Limited | Multivalent linkers for high loading antibody-drug conjugates, and compositions and methods thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK111489D0 (da) | 1989-03-08 | 1989-03-08 | Novo Nordisk As | Peptider |
| AU2001263775A1 (en) | 2000-06-02 | 2001-12-11 | Novo-Nordisk A/S | Glucose dependent release of insulin from glucose sensing insulin derivatives |
| EP1453860A2 (en) | 2001-12-02 | 2004-09-08 | Novo Nordisk A/S | Novel glucose-dependant insulins |
| JP2011506442A (ja) * | 2007-12-11 | 2011-03-03 | コンジュケム バイオテクノロジーズ インコーポレイテッド | インスリン分泌性ペプチド結合体の製剤 |
| FR2929615B1 (fr) | 2008-04-02 | 2010-12-17 | Tfchem | Composes c-aryl glycosides pour le traitement du diabete et de l'obesite. |
| CN101638423B (zh) | 2008-07-29 | 2012-09-05 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 根皮苷衍生物及其制备方法和用途 |
| AU2009294606A1 (en) | 2008-09-19 | 2010-03-25 | Novartis Ag | Glycoside derivatives and uses thereof |
| RU2011135730A (ru) | 2009-01-28 | 2013-03-10 | Смартселлз, Инк. | Кристаллические инсулин-коньюгаты |
| WO2010088294A1 (en) | 2009-01-28 | 2010-08-05 | Smartcells, Inc. | Conjugate based systems for controlled drug delivery |
| WO2010107520A1 (en) | 2009-03-20 | 2010-09-23 | Smartcells, Inc. | Soluble non-depot insulin conjugates and uses thereof |
| EP2448962B1 (en) | 2009-06-30 | 2016-10-19 | Novo Nordisk A/S | Insulin derivatives |
| EP2549863A4 (en) * | 2010-03-24 | 2014-01-01 | Univ Ohio | COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORTATION |
| WO2012015681A2 (en) | 2010-07-28 | 2012-02-02 | Smartcells, Inc. | Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
| JP2013535467A (ja) | 2010-07-28 | 2013-09-12 | スマートセルズ・インコーポレイテツド | 組換えにより発現されたインスリンポリペプチドおよびその使用 |
| JP2014510782A (ja) | 2011-04-14 | 2014-05-01 | ノバルティス アーゲー | グリコシド誘導体およびその使用 |
| WO2012177701A2 (en) | 2011-06-20 | 2012-12-27 | Radiomedix Inc. | Compositions, methods of synthesis and use of carbohydrate targeted agents |
| CA2864432A1 (en) | 2012-02-15 | 2013-08-22 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
| US20150086521A1 (en) | 2012-03-21 | 2015-03-26 | Erytech Pharma | Medicament for the Treatment of Acute Myeloid Leukemia (AML) |
| WO2013182612A1 (en) * | 2012-06-07 | 2013-12-12 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
| EP2813234A1 (en) | 2013-06-11 | 2014-12-17 | Erytech Pharma | Composition of erythrocytes encapsulating phenylalanine hydroxylase and therapeutic use thereof |
| US9884125B2 (en) | 2013-10-04 | 2018-02-06 | Merck Sharp & Dohme Corp. | Glucose-responsive insulin conjugates |
| LT3094731T (lt) | 2014-01-15 | 2019-10-25 | Baseclick Gmbh | Sacharidais modifikuotos nukleorūgšties molekulės |
| FR3017299B1 (fr) | 2014-02-12 | 2018-05-18 | Erytech Pharma | Composition pharmaceutique comprenant des erythrocytes encapsulant une enzyme a plp et son cofacteur |
| CN108778318B (zh) * | 2016-01-14 | 2022-05-03 | 北卡罗莱纳州立大学 | 葡萄糖响应性胰岛素递送组合物和方法 |
| MX2018014929A (es) | 2016-06-02 | 2019-08-26 | Sanofi Sa | Conjugados de un agente farmaceutico y una porcion capaz de unirse a una proteina sensora de glucosa. |
-
2017
- 2017-06-02 MX MX2018014929A patent/MX2018014929A/es unknown
- 2017-06-02 CN CN201780047924.9A patent/CN109562185A/zh active Pending
- 2017-06-02 RU RU2018147235A patent/RU2018147235A/ru not_active Application Discontinuation
- 2017-06-02 BR BR112018074716-5A patent/BR112018074716A2/pt not_active Application Discontinuation
- 2017-06-02 SG SG11201810701XA patent/SG11201810701XA/en unknown
- 2017-06-02 JP JP2018563040A patent/JP2019520342A/ja not_active Ceased
- 2017-06-02 AU AU2017272862A patent/AU2017272862A1/en not_active Abandoned
- 2017-06-02 WO PCT/EP2017/063447 patent/WO2017207754A1/en not_active Ceased
- 2017-06-02 EP EP17730714.7A patent/EP3463480A1/en not_active Withdrawn
- 2017-06-02 KR KR1020187038181A patent/KR20190015413A/ko not_active Ceased
- 2017-06-02 US US16/306,243 patent/US11090364B2/en active Active
- 2017-06-02 CA CA3025988A patent/CA3025988A1/en not_active Abandoned
-
2018
- 2018-11-29 IL IL263390A patent/IL263390A/en unknown
-
2021
- 2021-06-23 US US17/356,339 patent/US20210401947A1/en not_active Abandoned
- 2021-06-23 US US17/356,294 patent/US20210401946A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019520342A (ja) | 2019-07-18 |
| EP3463480A1 (en) | 2019-04-10 |
| MX2018014929A (es) | 2019-08-26 |
| US20210401946A1 (en) | 2021-12-30 |
| AU2017272862A1 (en) | 2019-01-17 |
| BR112018074716A2 (pt) | 2019-03-12 |
| SG11201810701XA (en) | 2018-12-28 |
| WO2017207754A1 (en) | 2017-12-07 |
| CN109562185A (zh) | 2019-04-02 |
| US20190209656A1 (en) | 2019-07-11 |
| RU2018147235A (ru) | 2020-07-10 |
| US20210401947A1 (en) | 2021-12-30 |
| IL263390A (en) | 2018-12-31 |
| KR20190015413A (ko) | 2019-02-13 |
| US11090364B2 (en) | 2021-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210401947A1 (en) | Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein | |
| US11981666B2 (en) | GLP-1 receptor agonist and composition and use thereof | |
| AU2025275263A1 (en) | Targeting ligands | |
| US11939349B2 (en) | Galactoside inhibitor of galectins | |
| ES2618024T3 (es) | Derivado de éster de ácido carboxílico heterocíclico | |
| KR20220004978A (ko) | 단백질 분해 표적 키메라 리간드로서 사용하기 위한 안드로겐 수용체 조절제 및 방법 | |
| KR20240036604A (ko) | Asgpr 세포 표면 수용체 결합 화합물 및 접합체 | |
| BRPI0607248A2 (pt) | conjugado de um polipeptìdeo e um oligossacarìdeo, composição farmacêutica, uso do conjugado, e, processo para a preparação de um conjugado | |
| CA2788782A1 (en) | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators | |
| CN114555620A (zh) | 半乳糖凝集素的新型半乳糖苷抑制剂 | |
| KR20120046162A (ko) | 2,3-디히드로-1h-인덴 화합물 및 이의 암치료 용도 | |
| EP2998294A1 (en) | Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | |
| CN118894846A (zh) | 一种含硒元素类化合物及其用途 | |
| JP7439062B2 (ja) | グルコース感受性インスリンおよびその使用 | |
| BRPI0920936A2 (pt) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimiocinas | |
| WO2025207934A1 (en) | Lysosomal targeting bifunctional molecules for degradation of thyroid stimulating hormone receptor autoantibodies | |
| US20230364251A1 (en) | Methods for the synthesis of protein-drug conjugates | |
| US20240150351A1 (en) | Bicyclic compounds | |
| US20210170033A1 (en) | Novel conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein | |
| WO2023144240A1 (en) | Glucose sensitive insulin derivatives and uses thereof | |
| AU2017376818A1 (en) | Heparanase inhibitors and use thereof | |
| RS67310B1 (sr) | Derivat aril glukozida i njegova upotreba u leku | |
| WO2026044024A1 (en) | Compositions comprising combinations of pharmaceutically acceptable salts and other derivatives of glucagon-like peptide-1 receptor agonist and pharmaceutically acceptable salts and other derivatives of amylin analog, and uses thereof | |
| CN114599643A (zh) | 一种芳基葡糖苷衍生物 | |
| BR112019004178B1 (pt) | Ligantes de direcionamento, compostos, composição, uso terapêutico dos compostos, da composição e dos ligantes de direcionamento e ainda métodos que utilizam os ditos ligantes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20221202 |